AREC Insider Trading

Insider Ownership Percentage: 25.34%
Insider Buying (Last 12 Months): £39,178.69
Insider Selling (Last 12 Months): GBX 0

Arecor Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Arecor Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Arecor Therapeutics Share Price & Price History

Current Price: GBX 42.50
Price Change: Price Decrease of -1 (-2.30%)
As of 06/18/2025 01:02 PM ET

This chart shows the closing price history over time for AREC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Arecor Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/19/2025Andrew RichardsInsiderBuy31,750GBX 47£14,922.50
5/19/2025Sarah Jennifer HowellInsiderBuy21,077GBX 47£9,906.19
5/13/2025Andrew RichardsInsiderBuy35,000GBX 41£14,350
See Full Table

SEC Filings (Institutional Ownership Changes) for Arecor Therapeutics (LON:AREC)

44.05% of Arecor Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Arecor Therapeutics logo
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio. For further details please see our website, www.arecor.com
Read More on Arecor Therapeutics

Today's Range

Now: GBX 42.50
Low: 42.03
High: 43.50

50 Day Range

MA: GBX 40.79
Low: 36
High: 45.15

52 Week Range

Now: GBX 42.50
Low: 35.40
High: 125

Volume

19,529 shs

Average Volume

23,620 shs

Market Capitalization

£16.05 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Arecor Therapeutics?

Arecor Therapeutics' top insider investors include:
  1. Andrew Richards (Insider)
  2. Sarah Jennifer Howell (Insider)
Learn More about top insider investors at Arecor Therapeutics.